Collecting images of skin lesions using a special camera
Image Data Collection Using a Multi-spectral Camera for Computer Vision Algorithms Research and Development
NA · Lumenis Be Ltd. · NCT05674149
This study is testing a special camera to take detailed pictures of skin lesions in adults to help improve how we diagnose and treat skin conditions.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 210 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Lumenis Be Ltd. (industry) |
| Locations | 1 site (Afula) |
| Trial ID | NCT05674149 on ClinicalTrials.gov |
What this trial studies
This observational study involves capturing high-quality images of various skin lesions using a multi-spectral camera. Patients presenting with specific skin conditions at the clinic will have their lesions photographed, along with reference images of unaffected skin. The goal is to gather data that can be used to develop computer vision algorithms for better diagnosis and treatment of these conditions. The study is open to any consenting adult patient with the required lesions.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older presenting with specific skin lesions such as melasma, seborrheic keratosis, or facial rosacea.
Not a fit: Patients without the specified skin lesions or those who do not wish to participate in the imaging process may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of diagnosing and treating skin lesions through advanced imaging techniques.
How similar studies have performed: While similar imaging techniques have been explored, this specific approach using a multi-spectral camera for skin lesions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Subjects must meet all the following inclusion criteria to be entered into the study: Any patient, male or female of at least 18 years old, who is willing to sign an informed consent form and present at least one of the following conditions: 1. Photoaging (type I - III per Glogau classification)- mixed conditions 2. Epidermal pigmentation / Lentigines (age spots, sun spots) 3. Facial rosacea (Erythematotelangiectatic rosacea and papulopustular rosacea) 4. Facial telangiectasia 5. Poikiloderma 6. Seborrheic keratosis 7. Melasma (Chloasma) Exclusion Criteria: Any of the following will exclude the subject from the study: The study is intended to gather image data so, any patient can be included in the study, and no exclusion criteria apply.
Where this trial is running
Afula
- Ha'Emek Medical Center — Afula, Israel (RECRUITING)
Study contacts
- Study coordinator: Rula Masoud, PhD
- Email: rula.masoud@lumenis.com
- Phone: 0503018155
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Vascular Lesion, Pigmented Lesions